144 related articles for article (PubMed ID: 6691342)
1. The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome.
Pardo V; Riesgo I; Zilleruelo G; Strauss J
Am J Kidney Dis; 1984 Jan; 3(4):264-9. PubMed ID: 6691342
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome].
Maruyama M; Toyoda M; Umezono T; Miyauchi M; Yamamoto N; Kimura M; Honma M; Nishina M; Endoh M; Sakai H; Suzuki D
Nihon Jinzo Gakkai Shi; 2006; 48(1):14-21. PubMed ID: 16480062
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
[TBL] [Abstract][Full Text] [Related]
4. Pure mesangial proliferative glomerulonephritis. A clinicomorphologic analysis and its possible role in morphologic transition of minimal change lesion.
Andal A; Saxena S; Chellani HK; Sharma S
Nephron; 1989; 51(3):314-9. PubMed ID: 2918942
[TBL] [Abstract][Full Text] [Related]
5. Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits.
Cavallo T; Johnson MP
Nephron; 1981; 27(6):281-4. PubMed ID: 7266716
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance and long-term evolution of minimal change histopathologic variants and of IGM nephropathy among Egyptians.
Donia AF; Sobh MA; Moustafa FE; Bakr MA; Foda MA
J Nephrol; 2000; 13(4):275-81. PubMed ID: 10946807
[TBL] [Abstract][Full Text] [Related]
7. Immune deposits and mesangial hypercellularity in minimal change nephrotic syndrome: clinical relevance.
Allen WR; Travis LB; Cavallo T; Brouhard BH; Cunningham RJ
J Pediatr; 1982 Feb; 100(2):188-91. PubMed ID: 7057326
[TBL] [Abstract][Full Text] [Related]
8. Glomerulopathy with mesangial IgM deposits: long-term follow up of 64 children.
Zeis PM; Kavazarakis E; Nakopoulou L; Moustaki M; Messaritaki A; Zeis MP; Nicolaidou P
Pediatr Int; 2001 Jun; 43(3):287-92. PubMed ID: 11380926
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Cho MH; Hong EH; Lee TH; Ko CW
Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
[TBL] [Abstract][Full Text] [Related]
10. In vitro B-lymphocyte switch disturbance from IgM into IgG in IgM mesangial nephropathy.
Lin CY; Chen CH; Lee PP
Pediatr Nephrol; 1989 Jul; 3(3):254-8. PubMed ID: 2702103
[TBL] [Abstract][Full Text] [Related]
11. No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome.
Ji-Yun Y; Melvin T; Sibley R; Michael AF
Kidney Int; 1984 Jan; 25(1):100-6. PubMed ID: 6727121
[TBL] [Abstract][Full Text] [Related]
12. Significance of mesangial IgM deposition in "minimal change" nephrotic syndrome.
Vilches AR; Turner DR; Cameron JS; Ogg CS; Chantler C; Williams DG
Lab Invest; 1982 Jan; 46(1):10-5. PubMed ID: 7054586
[TBL] [Abstract][Full Text] [Related]
13. Significance of mesangial IgA deposition in minimal change nephrotic syndrome: a study of 60 cases.
Choi J; Jeong HJ; Lee HY; Kim PK; Lee JS; Han DS
Yonsei Med J; 1990 Sep; 31(3):258-63. PubMed ID: 2281685
[TBL] [Abstract][Full Text] [Related]
14. [Clinico-pathological evaluation of mesangial IgA deposition of minimal change with nephrotic syndrome].
Hamaguchi K; Tuchida H; Suzuki S; Miura Y; Nakazawa R; Suhara Y; Mimura N
Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1071-7. PubMed ID: 2287099
[TBL] [Abstract][Full Text] [Related]
15. Mononuclear cell subsets in IgM mesangial proliferative glomerulonephritis. A comparative study with minimal change nephrotic syndrome and immunonegative mesangial proliferative glomerulonephritis.
Garcia del Moral R; Gomez-Morales M; Cortes V; Aguayo ML; Gigosos RL; Lardelli P; Navas A; Aneiros J; Aguilar D
Nephron; 1993; 65(2):215-21. PubMed ID: 8247183
[TBL] [Abstract][Full Text] [Related]
16. Chronic relapsing minimal change nephrotic syndrome with or without mesangial deposits: long term follow-up.
Papadopoulou ZL; Jenis EH; Tina LU; Novello AC; Jose PA; Calcagno PL
Int J Pediatr Nephrol; 1982 Sep; 3(3):179-86. PubMed ID: 6754644
[No Abstract] [Full Text] [Related]
17. Mesangial IGM in minimal change glomerular disease: a clinicopathological study in a Malaysian population.
Looi LM; Wang F; Lam KL; Chua CT
Pathology; 1985 Jan; 17(1):41-4. PubMed ID: 3889788
[TBL] [Abstract][Full Text] [Related]
18. Incidence & significance of IgM mesangial deposits in relapsing idiopathic nephrotic syndrome of childhood.
Bhuyan UN; Srivastava RN
Indian J Med Res; 1987 Jul; 86():53-60. PubMed ID: 3692560
[No Abstract] [Full Text] [Related]
19. Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.
Swartz SJ; Eldin KW; Hicks MJ; Feig DI
Pediatr Nephrol; 2009 Jun; 24(6):1187-92. PubMed ID: 19219463
[TBL] [Abstract][Full Text] [Related]
20. [Morphometric studies on numerical area density of glomerular cells (nuclear section) in the pathogenetic evaluation of minimal glomerular abnormalities].
Wolf E; Hantschick M; Kache J; Zeisig A; Dschietzig W; Müller D
Zentralbl Allg Pathol; 1986; 132(5-6):477-85. PubMed ID: 3564732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
